Is Edwards Lifesciences Corporation overvalued?

Edwards Lifesciences Corporation (EW) looks overvalued — trading about 45% above its fair value.

Overvalued

Price

$107.15

Fair value

$58.80

Current P/E

58.6

Normal P/E

32.1

Market cap

$61.61B

Dividend yield

0.0%

Return on equity

9.7%

Sector

Healthcare

Fair value compares EW's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks